Cargando…

Epidemiology and Elimination of HCV-Related Liver Disease

Hepatitis C virus (HCV) infection, defined by active carriage of HCV RNA, affects nearly 1.0% of the worldwide population. The main risk factors include unsafe injection drug use and iatrogenic infections. Chronic HCV infection can promote liver damage, cirrhosis and hepatocellular carcinoma (HCC) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pradat, Pierre, Virlogeux, Victor, Trépo, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213504/ https://www.ncbi.nlm.nih.gov/pubmed/30301201 http://dx.doi.org/10.3390/v10100545

Ejemplares similares

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
por: Virlogeux, Victor, et al.
Publicado: (2017)

Noninvasive diagnosis in alcohol‐related liver disease
por: Hadefi, Alia, et al.
Publicado: (2020)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

Elimination of HCV in Russia: Barriers and Perspective
por: Isakov, Vasily, et al.
Publicado: (2022)

Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure
por: Polyak, Stephen J., et al.
Publicado: (2021)

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

Remaining challenges in HCV elimination
por: Capraru, Camelia, et al.
Publicado: (2021)

Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations
por: Fiore, Vito, et al.
Publicado: (2023)

HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
por: Flisiak, Robert, et al.
Publicado: (2022)

Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020
por: Feld, Jordan J., et al.
Publicado: (2021)

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
por: Hatu, Giorgiana, et al.
Publicado: (2014)

A model for individualized prediction of liver-related death in outpatients with alcohol-associated cirrhosis
por: Marot, Astrid, et al.
Publicado: (2023)

Eliminating HCV: a marathon, not a sprint
por: The Lancet Gastroenterology & Hepatology
Publicado: (2020)

HCV treatment in 2020: How to translate highly effective therapies into elimination strategies
por: Alshuwaykh, Omar, et al.
Publicado: (2020)

HCV and Oxidative Stress in the Liver
por: Ivanov, Alexander V., et al.
Publicado: (2013)

Epidemiology of Hepatitis C Virus (HCV) Infection
por: Sy, Theodore, et al.
Publicado: (2006)

Chronic HCV infection: epidemiological and clinical relevance
por: Zaltron, S, et al.
Publicado: (2012)

Hepatitis C treatment initiation in HIV-HCV coinfected patients
por: Cotte, Laurent, et al.
Publicado: (2016)

Hepatitis C Virus Serologic and Virologic Tests and Clinical Diagnosis of HCV-Related Liver Disease
por: Chevaliez, Stéphane, et al.
Publicado: (2006)

Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis
por: Marot, Astrid, et al.
Publicado: (2018)

Epidemiology of HCV infection in the Central European region
por: Urbánek, Petr, et al.
Publicado: (2016)

Impact of COVID-19 on global HCV elimination efforts
por: Blach, Sarah, et al.
Publicado: (2021)

Perspectives of hepatitis C virus (HCV) elimination in Poland
por: Flisiak, Robert, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on HCV elimination in Spain
por: Buti, Maria, et al.
Publicado: (2021)

Update on epidemiology of HCV in Italy: focus on the Calabria Region
por: Marascio, Nadia, et al.
Publicado: (2014)

Management of HCV Infection and Liver Transplantation
por: Schiano, Thomas D., et al.
Publicado: (2006)

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
por: Poizot-Martin, Isabelle, et al.
Publicado: (2015)

Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study
por: Wasitthankasem, Rujipat, et al.
Publicado: (2018)

High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2020)

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways
por: Mangia, Alessandra, et al.
Publicado: (2021)

Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication
por: Nahon, Pierre, et al.
Publicado: (2019)

Outcomes of an HCV elimination program targeting the Viennese MSM population
por: Jachs, Mathias, et al.
Publicado: (2021)

JavaScript Algorithm for Quantifier Elimination in Epidemiology
por: Kreso, Inda
Publicado: (2018)

Use cases for genetic epidemiology in malaria elimination
por: Dalmat, Ronit, et al.
Publicado: (2019)

Dietary strategies in non‐alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review
por: Hadefi, Alia, et al.
Publicado: (2023)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland
por: Chlabicz, Slawomir, et al.
Publicado: (2011)

The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management
por: Konstantinou, Dimitris, et al.
Publicado: (2015)

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
por: Pradat, Pierre, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jbdljf309mhbuacuigu43296c3